Optimal Single Dose Intrathecal Dexmedetomidine for Postoperative Analgesia
Study Details
Study Description
Brief Summary
Spinal anesthesia is a commonly used technique for lower limb surgeries offering better quality of postoperative analgesia, lower incidence of side effects, and shorter post-anesthesia care unit stay than general anesthesia. However, the relatively short duration of action of the currently available local anesthetics (LAs) make these advantages short-lived.
The risk for local anesthetic toxicity (LAST) increases with the trials to use higher concentrations or volumes of intrathecal local anesthetics to increase the duration of analgesia.
Dexmedetomidine has the potential to prolong the duration of perioperative analgesia without the need for using high doses of local anesthetics and hence with decreasing the potential risk of local anesthetic, but the increased likelihood adverse effects such as short term bradycardia and prolonged duration of motor block may offset these benefits.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
The aim of this study is to determine the optimal single-dose of intrathecal dexmedetomidine that prolongs the analgesic duration with the least possible side effects.
With the patients in the sitting position and the use of complete aseptic technique, 25G Whitacre spinal needles will be introduced through L2-L4 interspaces and after observing free flow of the CSF, a 3ml volume including bupivacaine 12.5mg in conjunction with dexmedetomidine (3 µg) will be injected in the first case, then the patient will be turned supine.
The dose of intrathecal DEX given to the next patient will be guided by modified Dixon's up-and-down method using 1.5 mg as a step size, which assumed to be of clinical importance.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Other: Intrathecal dexmedetomidine Up-down sequential allocation The dose of intrathecal DEX given to the next patient will be guided by modified Dixon's up-and-down method using 1.5 mg as a step size, which assumed to be of clinical importance |
Drug: Intrathecal dexmedetomidine
The dose of intrathecal DEX given to the next patient will be guided by modified Dixon's up-and-down method using 1.5 mg as a step size, which assumed to be of clinical importance
|
Outcome Measures
Primary Outcome Measures
- Duration of analgesia [For 13 hours after surgery]
The duration of analgesia, defined as the time from administering of intrathecal study solution (T0) to the time for the first rescue analgesic request
Secondary Outcome Measures
- Postoperative pain score [For 24 hours after surgery]
Using visual analog scale
- Onset of sensory blockade [For 1 hour after initiaion of spinal anesthesia]
Onset of sensory block time defined as the time elapsed from T0 to achieve the adequate sensory level for the planned surgery.
- Onset of motor blockade [For 2 hours after initiation of spinal anesthesia]
Onset of motor block time defined as the time elapsed from T0 to achieve the Bromage scale of 3
- Highest dermatome level of sensory blockade [For 4 hours after initiation of spinal anesthesia]
The highest dermatome level of sensory blockade and the time needed to achieve this level from the time of injection as well as time to two segment sensory regression after T0 will be recorded
- Time to motor regression [For 6 hours after initiation of spinal anesthesia]
Time to motor regression to a Bromage scale of 2
- Sedation score [For 24 hours after initiation of spinal anesthesia]
Sedation scores will be assessed using a sedation scale (awake and alert= 0; quietly awake= 1; asleep but easily roused= 2; deep sleep= 3).
- Postoperative nausea and vomiting [For 24 hours after initiation of spinal anesthesia]
The degree of nausea and vomiting. Nausea will be measured using a numerical rating system (none= 0; mild= 1; moderate= 2; severe= 3)
- Cumulative tramadol consumption [For 24 hours after surgery]
- Intraoperative bradycardia [For 4 hours after initiation of spinal anesthesia]
- Intraoperative use of ephedrine [For 4 hours after initiation of spinal anesthesia]
- Intraoperative use of atropine [For 4 hours after initiation of spinal anesthesia]
- Intraoperative use of supplemental fentanyl [For 4 hours after initiation of spinal anesthesia]
- Intraoperative use of midazolam [For 4 hours after initiation of spinal anesthesia]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
American Society of Anesthesiologists physical class I to II.
-
Patients scheduled for elective lower limb surgeries.
Exclusion Criteria:
-
Morbid obese patients.
-
Severe or uncompensated cardiovascular disease.
-
Significant renal disease.
-
Significant hepatic disease.
-
Pregnancy.
-
Lactating .
-
Heart block.
-
Bradyarrhythmias.
-
Receiving adrenergic receptor antagonist medications.
-
Receiving calcium channel blockers.
-
Patients with pacemakers.
-
Patients with implanted cardioverter defibrillator.
-
Allergy to the study medications.
-
Psychological disease.
-
Neurological disorders.
-
Communication barrier.
-
Mental disorders.
-
Epilepsy.
-
Drug or alcohol abuse.
-
Contraindications to spinal anaesthesia.
-
Receiving opioid analgesic medications within 24 h before the operation.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Mansoura university | Mansoura | DK | Egypt | 050 |
Sponsors and Collaborators
- Mansoura University
Investigators
- Principal Investigator: Samah Elkenany, MD, Lecturer of Anesthesia and Surgical Intensive Care
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- R ∕ 16.01.15